Lakefront Biotherapeutics NV Stock Price, News & Analysis
Company Description
Lakefront Biotherapeutics NV (NASDAQ: LKFT) is a publicly traded company. The company has a market capitalization of $1.9B, ranking #2,299 among all listed U.S. companies by market cap.
LKFT stock has gained 1.1% over the past year. Shares last traded at $28.94.
This page provides a comprehensive overview of LKFT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lakefront Biotherapeutics NV (LKFT) stock last traded at $28.94, down 0.24% from the previous close. Over the past 12 months, the stock has gained 1.1%. At a market capitalization of $1.9B, LKFT is classified as a small-cap stock with approximately 65.9M shares outstanding.
LKFT Rankings
Latest News
Lakefront Biotherapeutics NV has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all LKFT news →
SEC Filings
Lakefront Biotherapeutics NV has filed 4 recent SEC filings, including 4 Form 6-K. The most recent filing was submitted on June 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LKFT SEC filings →